Cost of breast cancer treatment in medicaid: Implications for state programs providing coverage for low-income women

Medical Care

Volumn 49, Issue 1, 2011, Pages 89-95

  Subramanian, Sujha ^a   Trogdon, Justin ^a   Ekwueme, Donatus U ^b   Gardner, James G ^b   Whitmire, J Timothy ^c   Rao, Chandrika ^c  

^a RTI INTERNATIONAL   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c NORTH CAROLINA DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

breast cancer; Medicaid; treatment cost

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER THERAPY; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; FEMALE; GOVERNMENT; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HUMAN; LOWEST INCOME GROUP; MEDICAID; PRIORITY JOURNAL;

AGE FACTORS; BREAST NEOPLASMS; COMORBIDITY; COSTS AND COST ANALYSIS; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MEDICAID; MIDDLE AGED; NEOPLASM STAGING; NORTH CAROLINA; POVERTY; SOCIOECONOMIC FACTORS; TIME FACTORS; UNITED STATES;

EID: 78650705164     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181f81c32     Document Type: Article

References (23)

1. US Cancer Statistics Working Group. United States cancer statistics: 1999 - 2005 incidence and mortality web-based report. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2009. Available at: www.cdc.gov/uscs.
2. Horner MJ, Ries LA, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute. Based on November 2008 SEER data submission, posted to the SEER web site, 2009. Available at http://seer.cancer.gov/csr/1975-2006/.
3. Americans at risk: one in three uninsured. A report from Families USA, March2009.Availableat http://www.familiesusa.org/resources/publications/reports/ americans-at-risk-findings.html.
4. Public Law 106-354. Available at: http://www.cdc.gov/cancer/nbccedp/ bccpdfs/publ354-106.pdf.
5. Centers for Disease Control and Prevention. The National Breast and Cervical Cancer Early Detection Program. Available at: http://www.cdc. gov/cancer/nbccedp/about.htm. Accessed August 31, 2009.
6. Federal Funds Information for States. Issue Brief 07-02: update on Medicaid breast and cervical cancer treatment. January 11, 2007. Available at: http://www.ffis.org/172101/98422.html.
7. French C, True S, McIntyre R, et al. State implementation of the Breast and Cervical Cancer Prevention and Treatment Act of 2000: a collaborative effort among government agencies. Public Health Rep. 2004;119: 279-285.
8. Lantz PM, Weisman CS, Itani Z. A disease-specific Medicaid expansion for women: the Breast and Cervical Cancer Prevention and Treatment Act of 2000. Womens Health Issues. 2003;13:79-92.
9. Brown ML, Riley GF, Schussler N, et al. Estimating health care costs related to cancer treatment from SEER-Medicare data. Med Care. 2002;40(suppl 8):IV-104-IV-117.
10. Warren JL, Brown ML, Fay MP, et al. Costs of treatment for elderly women with early stage breast cancer in fee-for-service settings. J Clin Oncol. 2002;20:307-316.
11. Collaborative Staging Task Force of the American Joint Committee on Cancer. Collaborative Staging. Manual and Coding Instructions, version 01.04.00. NIH Publication Number 04-5496. Jointly published by American Joint Committee on Cancer (Chicago, IL) and US Department of Health and Human Services (Bethesda, MD); 2004.
12. Charlson ME, Pompei P. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
13. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
14. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46:1075-1079.
15. WHO. International Classification of Diseases, Ninth Revision (ICD-9). Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. Vol 1. Geneva, Switzerland: World Health Organization; 1977.
16. Manning WG, Mullahy J. Estimating log models: to transform or not transform? J Health Econ. 2001;20:461-494.
17. Buntin MB, Zaslavsky AM. Too much ado about two-part models and transformation? Comparing methods of modeling Medicare expenditures. J Health Econ. 2004;23:525-542.
18. Barlow WE, Taplin SH, Yoshida CK, et al. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer. J Natl Cancer Inst. 2001;93:447-455.
19. Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst. 2006;98:1108-1117.
20. Oestreicher N, Ramsey SD, McCune JS, et al. The cost of adjuvant chemotherapy in patients with early-stage breast carcinoma. Cancer. 2005;104:2054-2062.
21. Ramsey SD, Zeliadt SB, Richardson LC, et al. Disenrollment from Medicaid after recent cancer diagnosis. Med Care. 2008;46:49-57.
22. Wilhide S, Henderson T. Community care of North Carolina: a provider-led strategy for delivering cost-effective primary care to Medicaid beneficiaries. Washington, DC: American Academy of Family Physicians; 2006.
23. Campbell JD, Ramsey SD. The costs of treating breast cancer in the US: a synthesis of published evidence. Pharmacoeconomics. 2009;27:199-209. doi: 10.2165/00019053-20092703000003.